Riskpilot← Back to searchSign inGet full accessEMKATT AS
ASActiveOrg 925697087Kuholmsveien 105, 4632 Kristiansand SGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
NOK 0
EBITDA margin
—
+44% vs 2023
Equity ratio
40.7%
Financial strength
Net profit 2024
NOK 1,4M
-30% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -21K | +44% |
| Net profit | NOK 1,4M | -30% |
| Total assets | NOK 8,7M | +53% |
| Equity | NOK 3,6M | +17% |
| Employees | 0 | — |
Legal name
EMKATT AS
Org number
925697087
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
24. september 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av legevirksomhet og investeringer i andre selskaper med lignende formål. Investering i eiendom, aksjer og verdipapirer og alt hva herved står i naturlig tilknytning. Selskapet kan også drive annen vanlig handel.
Address
Kuholmsveien 105, 4632 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −4 | −7 | −38 | −21 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | −4 | −7 | −38 | −21 |
| Net financials | 0 | 50 | 994 | 2 038 | 1 919 |
| Profit before tax | −6 | 46 | 987 | 2 000 | 1 898 |
| Tax | −0 | −0 | 1 | −0 | 502 |
| Net profit | −6 | 46 | 987 | 2 000 | 1 395 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 18 | 1 326 | 2 999 | 5 703 | 8 744 |
| Equity | 18 | 64 | 1 051 | 3 051 | 3 560 |
| Long-term debt | 0 | 0 | 685 | 2 631 | 2 886 |
| Short-term debt | 0 | 1 262 | 1 263 | 22 | 2 298 |
| Total debt | 0 | 1 262 | 1 948 | 2 652 | 5 184 |
EBITDA margin
-2121900.0%
This company
15.8%
Market median
-13429847% vs market
20202024
Equity ratio
40.7%
This company
38.2%
Market median
+7% vs market
20202024
Return on equity
39.2%
This company
18.4%
Market median
+113% vs market
20202024
Net profit margin
139544500.0%
This company
8.1%
Market median
+1722771505% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DL Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EMKATT AS 
EPLESKRINET ASBoard members of EMKATT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Lærum | Chief Executive Officer | 0 companies |
| Emma Hagerup Lærum | Board of Directors | 0 companies |
| Vibeke Hagerup Lærum | Board of Directors | 0 companies |